Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.